Cargando…
Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?
INTRODUCTION: The prevalence of HIV-associated neurocognitive disorders continues to rise despite the widespread use of antiretroviral therapy. We aimed to define the risk of neurocognitive dysfunction among smokers relative to nonsmokers. METHODS: We conducted a retrospective cohort study including...
Autores principales: | Tsima, Billy, Ratcliffe, Sarah Jane, Schnoll, Robert, Frank, Ian, Kolson, Dennis Larry, Gross, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493327/ https://www.ncbi.nlm.nih.gov/pubmed/29667531 http://dx.doi.org/10.1177/2325958218768018 |
Ejemplares similares
-
Heme oxygenase-1 promoter (GT)(n) polymorphism associates with HIV neurocognitive impairment
por: Garza, Rolando, et al.
Publicado: (2020) -
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
por: Kolson, Dennis L.
Publicado: (2022) -
Heme Oxygenase-1 Dysregulation in the Brain: Implications for HIV-Associated Neurocognitive Disorders
por: Ambegaokar, Surendra S, et al.
Publicado: (2014) -
HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
por: Lindl, Kathryn A., et al.
Publicado: (2010) -
Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders
por: McGuire, Jennifer L, et al.
Publicado: (2015)